Equities

Nanjing Vishee Medical Technology Co Ltd

688580:SHH

Nanjing Vishee Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)20.91
  • Today's Change-9.99 / -32.33%
  • Shares traded391.53k
  • 1 Year change-57.20%
  • Beta1.6830
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,1551,2481,366
Total Receivables, Net533236
Total Inventory403530
Prepaid expenses5.843.471.83
Other current assets, total0.760.920.46
Total current assets1,2551,3191,434
Property, plant & equipment, net322173100
Goodwill, net6969--
Intangibles, net12110619
Long term investments22----
Note receivable - long term------
Other long term assets------
Total assets1,8061,6841,639
LIABILITIES
Accounts payable18209.28
Accrued expenses323627
Notes payable/short-term debt000
Current portion long-term debt/capital leases01.191.18
Other current liabilities, total1017267
Total current liabilities152129104
Total long term debt001.81
Total debt01.192.99
Deferred income tax0.480.55--
Minority interest----0
Other liabilities, total27260
Total liabilities179156106
SHAREHOLDERS EQUITY
Common stock696968
Additional paid-in capital1,1121,0911,086
Retained earnings (accumulated deficit)473383378
Treasury stock - common(26)(15)--
Unrealized gain (loss)------
Other equity, total------
Total equity1,6271,5291,533
Total liabilities & shareholders' equity1,8061,6841,639
Total common shares outstanding959696
Treasury shares - common primary issue0.700.450
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.